THOMAS F RYAN JR Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for THOMAS F RYAN JR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of THOMAS F RYAN JR. THOMAS F RYAN JR is Director in REPLIGEN CORP ($RGEN).
Latest Insider Trading Transactions of THOMAS F RYAN JR
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16 2021 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Gift | G | 0.00 | 170 | 0 | 1,294 | 1.5 K to 1.3 K (-11.61 %) |
| Mar 04 2021 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 26.12 | 1,000 | 26,120 | 0 | |
| Mar 04 2021 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 205.00 | 1,000 | 205,000 | 1,464 | 2.5 K to 1.5 K (-40.58 %) |
| Mar 04 2021 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 26.12 | 1,000 | 26,120 | 2,464 | 1.5 K to 2.5 K (+68.31 %) |
| Nov 13 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 38.76 | 934 | 36,202 | 1,000 | |
| Nov 13 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 187.73 | 934 | 175,340 | 1,464 | 2.4 K to 1.5 K (-38.95 %) |
| Nov 13 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 38.76 | 934 | 36,202 | 1,000 | |
| Nov 13 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 38.76 | 934 | 36,202 | 2,398 | 1.5 K to 2.4 K (+63.80 %) |
| Nov 13 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 187.73 | 934 | 175,340 | 1,464 | 2.4 K to 1.5 K (-38.95 %) |
| Nov 13 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 38.76 | 934 | 36,202 | 2,398 | 1.5 K to 2.4 K (+63.80 %) |
| Aug 04 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 67.71 | 2,109 | 142,800 | 0 | |
| Aug 04 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 151.77 | 986 | 149,645 | 1,464 | 2.5 K to 1.5 K (-40.24 %) |
| Aug 04 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 151.96 | 2,109 | 320,484 | 2,450 | 4.6 K to 2.5 K (-46.26 %) |
| Aug 04 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 67.71 | 2,109 | 142,800 | 4,559 | 2.5 K to 4.6 K (+86.08 %) |
| May 19 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 128.18 | 1,285 | 164,711 | 1,285 | |
| May 19 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Grant | A | 0.00 | 527 | 0 | 2,450 | 1.9 K to 2.5 K (+27.41 %) |
| Mar 18 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 42.07 | 500 | 21,035 | 0 | |
| Mar 18 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 38.76 | 500 | 19,380 | 1,934 | |
| Mar 18 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 91.48 | 1,000 | 91,480 | 1,923 | 2.9 K to 1.9 K (-34.21 %) |
| Mar 18 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 42.07 | 500 | 21,035 | 2,923 | 2.4 K to 2.9 K (+20.64 %) |
| Mar 18 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 38.76 | 500 | 19,380 | 2,423 | 1.9 K to 2.4 K (+26.00 %) |
| Mar 05 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 42.07 | 2,804 | 117,964 | 500 | |
| Mar 05 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 41.19 | 1,992 | 82,050 | 0 | |
| Mar 05 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 88.82 | 4,796 | 425,981 | 1,923 | 6.7 K to 1.9 K (-71.38 %) |
| Mar 05 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 42.07 | 2,804 | 117,964 | 6,719 | 3.9 K to 6.7 K (+71.62 %) |
| Mar 05 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 41.19 | 1,992 | 82,050 | 3,915 | 1.9 K to 3.9 K (+103.59 %) |
| Mar 05 2020 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 85.72 | 2,225 | 190,727 | 1,923 | 4.1 K to 1.9 K (-53.64 %) |
| May 17 2019 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 67.71 | 2,109 | 142,800 | 2,109 | |
| May 17 2019 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Grant | A | 0.00 | 923 | 0 | 4,148 | 3.2 K to 4.1 K (+28.62 %) |
| Nov 06 2018 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 65.75 | 1,763 | 115,920 | 3,225 | 5 K to 3.2 K (-35.34 %) |
| Aug 24 2018 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 51.44 | 2,366 | 121,698 | 4,988 | 7.4 K to 5 K (-32.17 %) |
| May 17 2018 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 42.07 | 3,304 | 138,999 | 3,304 | |
| May 17 2018 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Grant | A | 0.00 | 1,486 | 0 | 9,286 | 7.8 K to 9.3 K (+19.05 %) |
| May 17 2018 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Gift | G | 0.00 | 900 | 0 | 7,800 | 8.7 K to 7.8 K (-10.34 %) |
| Mar 12 2018 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 18.12 | 3,696 | 66,972 | 0 | |
| Mar 12 2018 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 3.22 | 1,000 | 3,220 | 0 | |
| Mar 12 2018 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 36.16 | 4,696 | 169,792 | 8,700 | 13.4 K to 8.7 K (-35.06 %) |
| Mar 12 2018 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 18.12 | 3,696 | 66,972 | 13,396 | 9.7 K to 13.4 K (+38.10 %) |
| Mar 12 2018 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 3.22 | 1,000 | 3,220 | 9,700 | 8.7 K to 9.7 K (+11.49 %) |
| May 22 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 38.76 | 2,434 | 94,342 | 2,434 | |
| May 22 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Grant | A | 0.00 | 1,206 | 0 | 8,700 | 7.5 K to 8.7 K (+16.09 %) |
| Mar 31 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Gift | G | 0.00 | 350 | 0 | 7,494 | 7.8 K to 7.5 K (-4.46 %) |
| Mar 31 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Gift | G | 0.00 | 750 | 0 | 7,844 | 8.6 K to 7.8 K (-8.73 %) |
| Mar 22 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 3.22 | 4,000 | 12,880 | 1,000 | |
| Mar 22 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 34.83 | 4,000 | 139,321 | 8,594 | 12.6 K to 8.6 K (-31.76 %) |
| Mar 22 2017 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 3.22 | 4,000 | 12,880 | 12,594 | 8.6 K to 12.6 K (+46.54 %) |
| Sep 16 2016 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 32.58 | 2,700 | 87,979 | 9,394 | 12.1 K to 9.4 K (-22.33 %) |
| Jul 01 2016 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 26.60 | 5,000 | 133,010 | 12,094 | 17.1 K to 12.1 K (-29.25 %) |
| Jun 29 2016 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 3.22 | 5,000 | 16,100 | 5,000 | |
| Jun 29 2016 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | M | 3.22 | 5,000 | 16,100 | 5,000 | |
| Jun 29 2016 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 24.59 | 10,000 | 245,888 | 17,094 | 27.1 K to 17.1 K (-36.91 %) |
| Jun 29 2016 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 24.59 | 10,000 | 245,888 | 17,094 | 27.1 K to 17.1 K (-36.91 %) |
| Jun 29 2016 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 3.22 | 5,000 | 16,100 | 27,094 | 22.1 K to 27.1 K (+22.63 %) |
| Jun 29 2016 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | M | 3.22 | 5,000 | 16,100 | 27,094 | 22.1 K to 27.1 K (+22.63 %) |
| May 13 2016 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 26.12 | 3,366 | 87,920 | 3,366 | |
| May 13 2016 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Grant | A | 0.00 | 1,763 | 0 | 22,094 | 20.3 K to 22.1 K (+8.67 %) |
| Jun 02 2015 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Gift | G | 0.00 | 1,000 | 0 | 20,331 | 21.3 K to 20.3 K (-4.69 %) |
| May 26 2015 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 41.19 | 1,992 | 82,050 | 1,992 | |
| May 26 2015 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Grant | A | 0.00 | 1,019 | 0 | 21,331 | 20.3 K to 21.3 K (+5.02 %) |
| May 12 2015 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 37.19 | 20,000 | 743,800 | 20,312 | 40.3 K to 20.3 K (-49.61 %) |
| Mar 20 2015 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Sell | S | 32.62 | 10,000 | 326,187 | 40,312 | 50.3 K to 40.3 K (-19.88 %) |
| May 13 2010 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 4.96 | 20,000 | 99,200 | 144,000 | |
| Apr 30 2009 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 5.08 | 20,000 | 101,600 | 20,000 | |
| Sep 17 2007 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 4.29 | 20,000 | 85,800 | 20,000 | |
| Sep 18 2006 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 3.10 | 15,000 | 46,500 | 15,000 | |
| Dec 13 2005 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | P | 2.95 | 1,000 | 2,945 | 1,000 | 0 to 1,000 |
| Dec 13 2005 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | P | 2.95 | 1,000 | 2,945 | 1,000 | 0 to 1,000 |
| Dec 13 2005 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | P | 2.95 | 1,000 | 2,945 | 6,000 | 5 K to 6 K (+20.00 %) |
| Dec 13 2005 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | P | 2.95 | 5,000 | 14,725 | 50,000 | 45 K to 50 K (+11.11 %) |
| Sep 15 2005 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 3.38 | 15,000 | 50,700 | 15,000 | |
| Mar 14 2005 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | P | 1.72 | 2,000 | 3,440 | 3,000 | 1,000 to 3 K (+200.00 %) |
| Mar 14 2005 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | P | 1.72 | 10,000 | 17,200 | 45,000 | 35 K to 45 K (+28.57 %) |
| Sep 23 2004 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 1.91 | 15,000 | 28,650 | 15,000 | |
| Sep 23 2004 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Option Exercise | A | 1.91 | 15,000 | 28,650 | 15,000 | |
| Aug 16 2004 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | P | 1.59 | 10,000 | 15,900 | 35,000 | 25 K to 35 K (+40.00 %) |
| Feb 19 2004 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Grant | A | 3.12 | 5,000 | 15,600 | 25,000 | 20 K to 25 K (+25.00 %) |
| Dec 03 2003 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | P | 4.72 | 5,000 | 23,591 | 20,000 | 15 K to 20 K (+33.33 %) |
| Dec 03 2003 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | P | 4.96 | 1,000 | 4,960 | 1,000 | 0 to 1,000 |
| Dec 03 2003 | RGEN | REPLIGEN CORP | RYAN THOMAS F JR | Director | Buy | P | 4.95 | 5,000 | 24,737 | 15,000 | 10 K to 15 K (+50.00 %) |
Page: 1